Yu Kaku

1.1k total citations
5 papers, 11 citations indexed

About

Yu Kaku is a scholar working on Virology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Yu Kaku has authored 5 papers receiving a total of 11 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Virology, 3 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Immunology. Recurrent topics in Yu Kaku's work include HIV Research and Treatment (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Immune Cell Function and Interaction (2 papers). Yu Kaku is often cited by papers focused on HIV Research and Treatment (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Immune Cell Function and Interaction (2 papers). Yu Kaku collaborates with scholars based in Japan, United States and South Korea. Yu Kaku's co-authors include Shuzo Matsushita, Takeo Kuwata, Miroslaw K. Górny, Yi Wang, Xiaolong Li, Kei Sato, Hirokazu Tamamura, Thomas Walz, Hiroshi Morioka and Ellis L. Reinherz and has published in prestigious journals such as Nature Communications, Vaccine and Immunology.

In The Last Decade

Yu Kaku

5 papers receiving 11 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yu Kaku Japan	3	7	5	5	2	2	5	11
Jiyeon Kwon South Korea	2	8 1.1×	6 1.2×	5 1.0×	1 0.5×	2 1.0×	2	12
Lucas Barwick United States	3	8 1.1×	6 1.2×	6 1.2×		1 0.5×	3	19
Margaret Terry United States	3	10 1.4×	4 0.8×	4 0.8×	2 1.0×	2 1.0×	3	18
Shijie Zou China	3	7 1.0×	3 0.6×	5 1.0×		5 2.5×	3	17
Ntombifuthi Mthabela South Africa	2	8 1.1×	10 2.0×	4 0.8×	1 0.5×	3 1.5×	2	20
Brittany Sunshine United States	2	4 0.6×	4 0.8×	4 0.8×			2	7
Pedro Simoes United Kingdom	1	7 1.0×	10 2.0×	3 0.6×			2	10
Aroa Nieto Spain	2	8 1.1×	6 1.2×	2 0.4×		2 1.0×	2	12
Miguel Górgolas Hernández-Mora Spain	3	4 0.6×	7 1.4×	2 0.4×		2 1.0×	8	15

Countries citing papers authored by Yu Kaku

Since Specialization

Citations

This map shows the geographic impact of Yu Kaku's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Kaku with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Kaku more than expected).

Fields of papers citing papers by Yu Kaku

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Kaku. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Kaku. The network helps show where Yu Kaku may publish in the future.

Co-authorship network of co-authors of Yu Kaku

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Kaku. A scholar is included among the top collaborators of Yu Kaku based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Kaku. Yu Kaku is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Uriu, Keiya, Yu Kaku, Minoru Kihara, & Kei Sato. (2025). Antiviral humoral immunity against SARS-CoV-2 omicron JN.1 subvariants induced by JN.1 recombinant protein vaccine. Vaccine. 54. 127129–127129. 1 indexed citations

2.

Tan, Kemin, Junjian Chen, Yu Kaku, et al.. (2023). Inadequate structural constraint on Fab approach rather than paratope elicitation limits HIV-1 MPER vaccine utility. Nature Communications. 14(1). 7218–7218. 2 indexed citations

3.

Kuwata, Takeo, et al.. (2023). Idiotopes of antibodies against HIV‐1 CD4‐induced epitope shared with those against microorganisms. Immunology. 171(4). 534–548. 2 indexed citations

4.

Kuwata, Takeo, et al.. (2021). Functional analysis of a monoclonal antibody reactive against the C1C2 of Env obtained from a patient infected with HIV-1 CRF02_AG. Retrovirology. 18(1). 23–23. 3 indexed citations

5.

Kaku, Yu, Takeo Kuwata, Miroslaw K. Górny, & Shuzo Matsushita. (2020). Prediction of Contact Residues in Anti-HIV Neutralizing Antibody by Deep Learning. Japanese Journal of Infectious Diseases. 73(3). 235–241. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact